MIAT promotes tumor-infiltrating CD8+ T-cell exhaustion and malignant progression of renal cell carcinoma via activating JAK3/STAT3 pathway
Background The hyporesponsiveness of tumor-infiltrating exhausted CD8+ T cells to tumor cells contributes to immune escape of renal cell carcinoma (RCC), representing a major challenge in current immunotherapy. However, the underlying molecular mechanism of CD8+ T-cell exhaustion in the tumor microe...
Saved in:
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2025-07-01
|
| Series: | Journal for ImmunoTherapy of Cancer |
| Online Access: | https://jitc.bmj.com/content/13/7/e011162.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849706426660814848 |
|---|---|
| author | Bin Wang Jian-Feng Wang Jun-Hang Luo Ming-xiao Zhang Lan-yu Jing Hao-tian Tan Zi-ran Dai Da-zhi Long Han-chao Liu An-ze Yu Zi-yin Chen Zhen-hua Chen |
| author_facet | Bin Wang Jian-Feng Wang Jun-Hang Luo Ming-xiao Zhang Lan-yu Jing Hao-tian Tan Zi-ran Dai Da-zhi Long Han-chao Liu An-ze Yu Zi-yin Chen Zhen-hua Chen |
| author_sort | Bin Wang |
| collection | DOAJ |
| description | Background The hyporesponsiveness of tumor-infiltrating exhausted CD8+ T cells to tumor cells contributes to immune escape of renal cell carcinoma (RCC), representing a major challenge in current immunotherapy. However, the underlying molecular mechanism of CD8+ T-cell exhaustion in the tumor microenvironment remains largely unknown.Methods We first examined myocardial infarction associated transcript (MIAT) expression in RCC cell lines and clinical specimens, and analyzed its correlation with CD8+ T-cell exhaustion markers. To investigate the immunoregulatory role of MIAT, we evaluated its effects on CD8+ T-cell function using T-cell co-culture systems and humanized-peripheral blood mononuclear cells RCC patient-derived xenograft models. To determine the direct effects of MIAT on tumor cells, we assessed RCC cell malignant phenotypes following MIAT knockdown both in vitro and in immunodeficient nude mouse orthotopic xenograft models. Mechanistically, we employed RNA fluorescence in situ hybridization, chromatin isolation by RNA purification followed by mass spectrometry, RNA immunoprecipitation, and chromatin immunoprecipitation assays to identify the molecular interactions between MIAT, transcription factors, and target genes.Results MIAT was highly expressed in RCC cells and positively correlated with CD8+ T-cell exhaustion status. MIAT knockdown significantly enhanced CD8+ T-cell function with increased perforin and interferon-γ production, while reducing the expression of exhaustion markers programmed cell death protein 1 and T-cell immunoreceptor with Ig and ITIM domains. Mechanistically, MIAT was predominantly localized in the nucleus and formed a trimeric complex with transcription factor ETS proto-oncogene 1 (ETS1) and janus kinase 3 (JAK3) promoter, thereby upregulating JAK3 expression and activating the JAK3/signal transducer and activator of transcription 3 (STAT3) signaling pathway. Importantly, ectopic expression of JAK3 largely abolished both the tumor-suppressive effects and enhanced T-cell function induced by MIAT depletion.Conclusions Our study demonstrates that the MIAT/JAK3/STAT3 pathway plays a critical role in malignant progression and immune escape of RCC through regulating CD8+ T-cell exhaustion, suggesting its potential as a therapeutic target for RCC immunotherapy. |
| format | Article |
| id | doaj-art-05bcffd4bb814c0aa6dfd0b1ceb0642a |
| institution | DOAJ |
| issn | 2051-1426 |
| language | English |
| publishDate | 2025-07-01 |
| publisher | BMJ Publishing Group |
| record_format | Article |
| series | Journal for ImmunoTherapy of Cancer |
| spelling | doaj-art-05bcffd4bb814c0aa6dfd0b1ceb0642a2025-08-20T03:16:12ZengBMJ Publishing GroupJournal for ImmunoTherapy of Cancer2051-14262025-07-0113710.1136/jitc-2024-011162MIAT promotes tumor-infiltrating CD8+ T-cell exhaustion and malignant progression of renal cell carcinoma via activating JAK3/STAT3 pathwayBin Wang0Jian-Feng Wang1Jun-Hang Luo2Ming-xiao Zhang3Lan-yu Jing4Hao-tian Tan5Zi-ran Dai6Da-zhi Long7Han-chao Liu8An-ze Yu9Zi-yin Chen10Zhen-hua Chen11Department of Breast Surgery, The First Affiliated Hospital of Xi`an Jiaotong University, Xi`an, ChinaDepartment of Urology, China-Japan Friendship Hospital, Beijing, ChinaDepartment of Urology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, ChinaDepartment of Urology, China-Japan Friendship Hospital, Beijing, ChinaBreast Department, Guangdong Provincial Hospital of Chinese Medicine, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, The Second Clinical College of Guangzhou University of Chinese Medicine, Guangdong Provincial Academy of Medical Sciences, Guangzhou, ChinaDepartment of Urology, China-Japan Friendship Hospital, Beijing, ChinaDepartment of Urology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, ChinaDepartment of Urology, Ji`an Center People`s Hospital, Ji`an, ChinaDepartment of Andrology and Urology, Sir Run Run Shaw Hospital, affiliated with the Zhejiang University School of Medicine, Hangzhou, ChinaDepartment of Urology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, ChinaDepartment of Urology, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, ChinaDepartment of Urology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, ChinaBackground The hyporesponsiveness of tumor-infiltrating exhausted CD8+ T cells to tumor cells contributes to immune escape of renal cell carcinoma (RCC), representing a major challenge in current immunotherapy. However, the underlying molecular mechanism of CD8+ T-cell exhaustion in the tumor microenvironment remains largely unknown.Methods We first examined myocardial infarction associated transcript (MIAT) expression in RCC cell lines and clinical specimens, and analyzed its correlation with CD8+ T-cell exhaustion markers. To investigate the immunoregulatory role of MIAT, we evaluated its effects on CD8+ T-cell function using T-cell co-culture systems and humanized-peripheral blood mononuclear cells RCC patient-derived xenograft models. To determine the direct effects of MIAT on tumor cells, we assessed RCC cell malignant phenotypes following MIAT knockdown both in vitro and in immunodeficient nude mouse orthotopic xenograft models. Mechanistically, we employed RNA fluorescence in situ hybridization, chromatin isolation by RNA purification followed by mass spectrometry, RNA immunoprecipitation, and chromatin immunoprecipitation assays to identify the molecular interactions between MIAT, transcription factors, and target genes.Results MIAT was highly expressed in RCC cells and positively correlated with CD8+ T-cell exhaustion status. MIAT knockdown significantly enhanced CD8+ T-cell function with increased perforin and interferon-γ production, while reducing the expression of exhaustion markers programmed cell death protein 1 and T-cell immunoreceptor with Ig and ITIM domains. Mechanistically, MIAT was predominantly localized in the nucleus and formed a trimeric complex with transcription factor ETS proto-oncogene 1 (ETS1) and janus kinase 3 (JAK3) promoter, thereby upregulating JAK3 expression and activating the JAK3/signal transducer and activator of transcription 3 (STAT3) signaling pathway. Importantly, ectopic expression of JAK3 largely abolished both the tumor-suppressive effects and enhanced T-cell function induced by MIAT depletion.Conclusions Our study demonstrates that the MIAT/JAK3/STAT3 pathway plays a critical role in malignant progression and immune escape of RCC through regulating CD8+ T-cell exhaustion, suggesting its potential as a therapeutic target for RCC immunotherapy.https://jitc.bmj.com/content/13/7/e011162.full |
| spellingShingle | Bin Wang Jian-Feng Wang Jun-Hang Luo Ming-xiao Zhang Lan-yu Jing Hao-tian Tan Zi-ran Dai Da-zhi Long Han-chao Liu An-ze Yu Zi-yin Chen Zhen-hua Chen MIAT promotes tumor-infiltrating CD8+ T-cell exhaustion and malignant progression of renal cell carcinoma via activating JAK3/STAT3 pathway Journal for ImmunoTherapy of Cancer |
| title | MIAT promotes tumor-infiltrating CD8+ T-cell exhaustion and malignant progression of renal cell carcinoma via activating JAK3/STAT3 pathway |
| title_full | MIAT promotes tumor-infiltrating CD8+ T-cell exhaustion and malignant progression of renal cell carcinoma via activating JAK3/STAT3 pathway |
| title_fullStr | MIAT promotes tumor-infiltrating CD8+ T-cell exhaustion and malignant progression of renal cell carcinoma via activating JAK3/STAT3 pathway |
| title_full_unstemmed | MIAT promotes tumor-infiltrating CD8+ T-cell exhaustion and malignant progression of renal cell carcinoma via activating JAK3/STAT3 pathway |
| title_short | MIAT promotes tumor-infiltrating CD8+ T-cell exhaustion and malignant progression of renal cell carcinoma via activating JAK3/STAT3 pathway |
| title_sort | miat promotes tumor infiltrating cd8 t cell exhaustion and malignant progression of renal cell carcinoma via activating jak3 stat3 pathway |
| url | https://jitc.bmj.com/content/13/7/e011162.full |
| work_keys_str_mv | AT binwang miatpromotestumorinfiltratingcd8tcellexhaustionandmalignantprogressionofrenalcellcarcinomaviaactivatingjak3stat3pathway AT jianfengwang miatpromotestumorinfiltratingcd8tcellexhaustionandmalignantprogressionofrenalcellcarcinomaviaactivatingjak3stat3pathway AT junhangluo miatpromotestumorinfiltratingcd8tcellexhaustionandmalignantprogressionofrenalcellcarcinomaviaactivatingjak3stat3pathway AT mingxiaozhang miatpromotestumorinfiltratingcd8tcellexhaustionandmalignantprogressionofrenalcellcarcinomaviaactivatingjak3stat3pathway AT lanyujing miatpromotestumorinfiltratingcd8tcellexhaustionandmalignantprogressionofrenalcellcarcinomaviaactivatingjak3stat3pathway AT haotiantan miatpromotestumorinfiltratingcd8tcellexhaustionandmalignantprogressionofrenalcellcarcinomaviaactivatingjak3stat3pathway AT zirandai miatpromotestumorinfiltratingcd8tcellexhaustionandmalignantprogressionofrenalcellcarcinomaviaactivatingjak3stat3pathway AT dazhilong miatpromotestumorinfiltratingcd8tcellexhaustionandmalignantprogressionofrenalcellcarcinomaviaactivatingjak3stat3pathway AT hanchaoliu miatpromotestumorinfiltratingcd8tcellexhaustionandmalignantprogressionofrenalcellcarcinomaviaactivatingjak3stat3pathway AT anzeyu miatpromotestumorinfiltratingcd8tcellexhaustionandmalignantprogressionofrenalcellcarcinomaviaactivatingjak3stat3pathway AT ziyinchen miatpromotestumorinfiltratingcd8tcellexhaustionandmalignantprogressionofrenalcellcarcinomaviaactivatingjak3stat3pathway AT zhenhuachen miatpromotestumorinfiltratingcd8tcellexhaustionandmalignantprogressionofrenalcellcarcinomaviaactivatingjak3stat3pathway |